Bleakley Financial Group’s Alkermes ALKS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-10,064
Closed -$356K 948
2026
Q1
$356K Sell
10,064
-4,668
-32% -$145K 0.01% 692
2025
Q4
$412K Buy
14,732
+2,414
+20% +$72.3K 0.01% 613
2025
Q3
$370K Sell
12,318
-1,743
-12% -$49.1K 0.01% 537
2025
Q2
$402K Sell
14,061
-1,683
-11% -$50.1K 0.01% 513
2025
Q1
$520K Sell
15,744
-105
-0.7% -$3.42K 0.02% 426
2024
Q4
$456K Buy
15,849
+4,335
+38% +$125K 0.01% 650
2024
Q3
$322K Sell
11,514
-49
-0.4% -$1.31K 0.01% 740
2024
Q2
$279K Sell
11,563
-582
-5% -$14.3K 0.01% 777
2024
Q1
$329K Buy
12,145
+353
+3% +$10K 0.01% 735
2023
Q4
$327K Sell
11,792
-1,268
-10% -$32.9K 0.01% 709
2023
Q3
$366K Sell
13,060
-3,055
-19% -$89.6K 0.01% 622
2023
Q2
$504K Buy
16,115
+2,895
+22% +$87.7K 0.02% 582
2023
Q1
$373K Buy
13,220
+1,374
+12% +$37.4K 0.01% 650
2022
Q4
$310K Buy
+11,846
New +$283K 0.01% 684

Other funds holding ALKS

Bleakley Financial Group's ALKS Position: Q2 2026 in Review

Bleakley Financial Group sold out of Alkermes (ALKS) in Q2 2026, closing a stake of 10,064 shares — an estimated $356K sold.

Bleakley Financial Group first reported a position in ALKS in Q4 2022 and held it in 14 quarters. The position peaked at $520K in Q1 2025. 166 funds tracked by Wall St. Rank hold ALKS as of Q2 2026.

  • Bleakley Financial Group reported no remaining Alkermes position as of Q2 2026 after selling out during the quarter.
  • Bleakley Financial Group sold 10,064 Alkermes shares in Q2 2026, an estimated $356K.
  • Bleakley Financial Group first reported a position in Alkermes in Q4 2022 and held it in 14 quarters.
  • Bleakley Financial Group's Alkermes position peaked at $520K in Q1 2025.
  • 166 funds tracked by Wall St. Rank held Alkermes as of Q2 2026.

Based on Bleakley Financial Group's 13F filing for Q2 2026, filed 5 Aug 2026.